| Literature DB >> 23943438 |
Abstract
Calpains are a family of Ca(2+)-dependent intracellular cysteine proteases, including the ubiquitously expressed μ-calpain (CANP1) and m-calpain (CANP2). The CANP1 has been found to play a central role in postmortem proteolysis and meat tenderization. However, the physiological roles of CANP1 in cattle skeletal satellite cells remain unclear. In this study, three small interference RNA sequences (siRNAs) targeting CANP1 gene were designed and ligated into pSilencer plasmid vector to construct shRNA expression constructs. Suppression of CANP1 in satellite cells was evaluated using these shRNA expressing constructs. Our results revealed that all three siRNAs could downregulate the expression of CANP1. Suppression of CANP1 significantly reduced cell viability in cell proliferation when compared with control cells. We found a crosstalk between CANP1 and caspase systems, particularly suppression of CANP1 resulted in an increase in the expressions of apoptotic caspases such as caspase-3, caspase-6, caspase-7, caspase-8, and caspase-9, as well as heat-shock protein (HSP) systems. Additionally, suppression of CANP1 led to the upregulation of other apoptosis and DNA damage-regulating genes whilst at the same time downregulating proliferation, migration, and differentiation-regulating genes. The results of our findings report for the first time that suppression of CANP1 resulted in the activation of caspase and HSP systems which might in turn regulate apoptosis through the caspase-dependent cell death pathway. This clearly demonstrates the key roles of CANP1 in regulation of cell proliferation and survival.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23943438 PMCID: PMC3825316 DOI: 10.1007/s11626-013-9666-5
Source DB: PubMed Journal: In Vitro Cell Dev Biol Anim ISSN: 1071-2690 Impact factor: 2.416
Figure 1.Agarose gel electrophoresis (1.8%) of colony plasmid DNA and CANP1-siRNAs digested with BamH I and Hind III. M: 100 bp DNA molecular weight marker; 4,885 bp of plasmid vector; 65 bp of CANP1-siRNA1, CANP1-siRNA2, and CANP1-siRNA3 oligonucleotides.
Figure 2.Knocking down of CANP1 in satellite cells analyzed at mRNA level and protein level. The mRNA and protein expression were assayed by RT-PCR and Western blot respectively following 24 h transfection. (A) RT-PCR with specific primers confirmed that CANP1 was silenced at the mRNA level. Value expressed as mean ± standard error of mean (SEM), calculated from three independent experiments. Gene expression was normalized to GAPDH expression and denoted as a gene/GAPDH ratio. *p < 0.05; (B) Showed Western blot graph; (C) showed relative densitometric values of Western blots. Western blot with anti-actin antibody was used as loading control.
Figure 3.Effect of CANP1 suppression on satellite cell viability in cell proliferation. (A) The proliferation of cells following transfections as indicated was assayed by the CCK-8 assay. Data represent the mean ± standard error of mean (SEM) of triplicates, *p < 0.05. Representative images of transfected cells which were taken by electronic microscope at ×40 magnification, (B) represents the control cells; (C) represents the CANP1-siRNA3-transfected cells; (D) represents the confocal scanning laser microscope (CSLM) image of control cells; (E) represents the CSLM image of CANP1-siRNA3-transfected cells. The cells were stained by DiOC18 (3)/PI. Dead cells are labeled by PI and have red nuclei. Live cells are labeled by DiOC18 (3) and have green nuclei.
Figure 4.CASP3, CASP7, CASP9, HSP27, HSP70, and HSP90 mRNA expression levels in satellite cells. The mRNA expressions of these genes were assayed by quantitative real-time PCR following 24 h transfection with shRNA expression constructs or control. (A) Showed the quantitative RT-PCR results of caspase-3, caspase-7, and caspase-9; (B) Showed the quantitative RT-PCR results of HSP27, HSP70, and HSP90. Values expressed as mean ± standard error of mean (SEM), calculated from three independent experiments. Gene expression was normalized to GAPDH expression and denoted as a gene/GAPDH ratio, *p < 0.05.
Figure 5.Knocking down of CANP1 in satellite cells analyzed at protein level of representative genes. Cells were transfected with CANP1-siRNA1, CANP1-siRNA2, and CANP1-siRNA3 expression constructs or control for 24 h. (A) showed Western blot graph of CASP9; (B) showed relative densitometric values of CASP9 Western blot. (C) Showed Western blot graph of HSP27; (D) showed relative densitometric values of HSP29 Western blot. (E) Showed Western blot graph of HSP90; (F) showed relative densitometric values of HSP90 Western blot. Western blot with anti-actin antibody was used as loading control.
Figure 6.Microarray analysis of CANP1, CASP3, CASP7, CASP9, HSP27, HSP70, and HSP90 gene expressions in satellite cells which were transfected with the representative CANP1-siRNA3 for 24 h. The expression level of transfected cells was calculated based on the respective control values.
Figure 7.Expression profiling of genes in CANP1-siRNA3-transfected cells and control cells. The gene expression profiles of transfected cells or control were assessed using microarray analysis. Genes present on the bovine gene expression microarray were plotted using a scatter plot. The position of each gene on the plot is determined by its expression levels in control (x-axis) and CANP1-siRNA-transfected cells (y-axis).
A total of 50 genes is significantly ≤3-fold downregulated following 24 h CANP1-siRNA3 transfection
| Functional category | Gene ID | Gene name | Species |
|---|---|---|---|
| Regulation of cell proliferation | NM_001076804 | GATA binding protein 3 |
|
| NM_001076198 | RAS-like, estrogen-regulated, growth inhibitor |
| |
| NM_001105340 | TNF receptor-associated factor 5 |
| |
| NM_001075986 | Adenomatous polyposis coli |
| |
| NM_173888 | Adrenomedullin |
| |
| NM_174501 | Arachidonate 15-lipoxygenase |
| |
| NM_181010 | Endothelin 1 |
| |
| NM_001083689 | Forkhead box P1 |
| |
| NM_001035463 | Glypican 3 |
| |
| NM_001105424 | Hematopoietically expressed homeobox |
| |
| NM_001102175 | Interleukin 20 receptor beta |
| |
| NM_001098385 | Keratin 4 |
| |
| NM_001076104 | Nuclear factor I/B |
| |
| NM_001167900 | Nuclear receptor subfamily 2, group E, member 3 |
| |
| NM_001040645 | Paired box 6 |
| |
| NM_181024 | Peroxisome proliferator-activated receptor gamma |
| |
| XM_613125 | Phosphatase and tensin homolog |
| |
| NM_174196 | Thrombospondin 1 |
| |
| Muscle cell differentiation | XM_001253596 | GATA-6 |
|
| NM_001015600 | Cytokeratin 19 |
| |
| NM_001081515 | Dual-specificity tyrosine |
| |
| NM_001083689 | Forkhead box P1 |
| |
| NM_001077843 | Low-density lipoprotein receptor-related protein 4 |
| |
| NM_001040478 | Myogenic differentiation 1 |
| |
| NM_001077988 | Neurotrophin 3 |
| |
| NM_173951 | Plasminogen |
| |
| NM_001076907 | Retinoblastoma1 |
| |
| Positive regulation of multicellular organismal process | NM_174537 | Fc fragment of IgE, high affinity I |
|
| NM_001076804 | GATA binding protein 3 |
| |
| NM_001077111 | Caspase recruitment domain family, member 9 |
| |
| NM_174270 | Cholinergic receptor, muscarinic 3 |
| |
| NM_173877 | Coagulation factor II (thrombin) |
| |
| NM_181010 | Endothelin 1 |
| |
| NM_001166609 | Heat-shock 60 kDa protein 1 (chaperonin) |
| |
| NM_001102175 | Interleukin 20 receptor beta |
| |
| NM_001038674 | Lipopolysaccharide binding protein |
| |
| NM_173951 | Plasminogen |
| |
| NM_174196 | Thrombospondin 1 |
| |
| Cell migration | NM_175796 | ATP synthase, mitochondrial F1 complex |
|
| NM_174009 | CD34 molecule |
| |
| NM_174537 | Fc fragment of IgE, receptor for gamma |
| |
| NM_001101171 | Abl interactor 2 |
| |
| NM_001075986 | Adenomatous polyposis coli |
| |
| NM_001113174 | Chemokine (C–X–C motif) ligand 12 |
| |
| NM_001075845 | Empty spiracles homeobox 2 |
| |
| NM_001110000 | Kinase insert domain receptor |
| |
| NM_181037 | Nitric oxide synthase 3 (endothelial cell) |
| |
| NM_175804 | Nuclear receptor subfamily 2, group F, member 1 |
| |
| NM_001034387 | Nucleoporin 85 kDa |
| |
| NM_174435 | Protein kinase C, alpha |
|
Totals of 64 genes are significantly ≥3-fold upregulated following 24 h CANP1-siRNA3 transfection
| Functional category | Gene ID | Gene name | Species |
|---|---|---|---|
| Defense/stress response | NM_001034735 | CD74 molecule, major histocompatibility complex |
|
| NM_001076918 | Toll-like receptor 10 |
| |
| NM_174263 | Chemokine (C–C motif) ligand 20 |
| |
| NM_175827 | Chemokine (C–C motif) ligand 5 |
| |
| NM_174299 | Chemokine (C–X–C motif) ligand 2 |
| |
| NM_001048165 | Chemokine (C–X–C motif) ligand 2 |
| |
| NM_001040526 | Complement factor B |
| |
| NM_174092 | Interleukin 1, alpha |
| |
| NM_173923 | Interleukin 6 (interferon, beta 2) |
| |
| NM_173925 | Interleukin 8 |
| |
| NM_174183 | Selectin P |
| |
| NM_174550 | Heat-shock 70 kDa protein 1A |
| |
| NM_001035293 | Heat-shock 70 kDa protein 8 |
| |
| Regulation of apoptosis/cell death program | NM_001034735 | CD74 molecule, major histocompatibility complex |
|
| NM_001075129 | Calcium channel, voltage-dependent, alpha 1A subunit |
| |
| NM_174006 | Chemokine (C–C motif) ligand 2 |
| |
| NM_174027 | Colony stimulating factor 2 (granulocyte-macrophage) |
| |
| NM_173924 | Interleukin 7 |
| |
| NM_001101074 | Nuclear apoptosis inducing factor 1 |
| |
| NM_001075911 | Nuclear receptor subfamily 4, group A, member 1 |
| |
| NM_001075344 | Transmembrane protein 102 |
| |
| NM_173966 | Tumor necrosis factor (TNF superfamily, member 2) |
| |
| NM_174092 | Interleukin 1, alpha |
| |
| NM_001076409 | Nuclear factor of kappa light polypeptide gene enhancer |
| |
| NM_001034536 | DnaJ (Hsp40) related, subfamily B, member 13 |
| |
| NM_001076031 | Cell death-inducing DFFA-like effector c |
| |
| NM_173923 | Interleukin 6 (interferon, beta 2) |
| |
| NM_001040490 | Tumor necrosis factor receptor superfamily, member 1B |
| |
| NM_001077840 | Caspase 3, apoptosis-related cysteine peptidase |
| |
| XM_604643 | Caspase 7, apoptosis-related cysteine peptidase |
| |
| NM_203322 | Heat shock 70 kDa protein 1A |
| |
| NM_001035419 | Caspase 6, apoptosis-related cysteine peptidase |
| |
| NM_001045970 | Caspase 8, apoptosis-related cysteine peptidase |
| |
| NM_001105611 | CD40 molecule, TNF receptor superfamily member 5 |
| |
| NM_001034676 | NK2 transcription factor related, locus 3 (Drosophila) |
| |
| NM_001079645 | Adenosine A3 receptor |
| |
| NM_001109796 | Caspase recruitment domain family, member 11 |
| |
| NM_174301 | Chemokine (C–X–C motif) receptor 4 |
| |
| NM_181030 | Fms-related tyrosine kinase 3 ligand |
| |
| NM_174348 | Intercellular adhesion molecule 1 |
| |
| NM_173925 | Interleukin 8 |
| |
| NM_001034320 | Jumonji domain containing 6 |
| |
| NM_001077855 | Protein kinase C, delta |
| |
| NM_001034610 | Receptor-interacting serine-threonine kinase 2 |
| |
| NM_001030301 | Toll-like receptor adaptor molecule 1 |
| |
| NM_001037100 | BCL2-related protein A1 |
| |
| NM_001075418 | Fas apoptotic inhibitory molecule 2 |
| |
| NM_001102219 | NLR family, pyrin domain containing 3 |
| |
| NM_001098930 | Proapoptotic caspase adapter protein |
| |
| NM_176638 | Caspase 4, apoptosis-related cysteine peptidase |
| |
| NM_001034509 | Caspase-15 |
| |
| NM_001103097 | Coagulation factor II (thrombin) receptor |
| |
| NM_001045979 | Complement component 6 |
| |
| NM_001035364 | Complement component 9 |
| |
| NM_001077963 | Cytochrome c, testis |
| |
| NM_001015669 | Deleted in bladder cancer 1 |
| |
| NM_001102091 | Engulfment and cell motility 3 |
| |
| NM_001075679 | Family with sequence similarity 82, member C |
| |
| NM_001040604 | Growth arrest and DNA-damage-inducible, beta |
| |
| NM_001045901 | Growth arrest and DNA-damage-inducible, gamma |
| |
| NM_001046113 | Myocyte enhancer factor 2C |
| |
| NM_001046178 | Protein phosphatase 1, regulatory (inhibitor) subunit 15A |
| |
| Response to DNA damage stimuli | NM_001077840 | Caspase 3, apoptosis-related cysteine peptidase |
|
| NM_203322 | Heat shock 70 kDa protein 1A |
|